Microbial biotransformation of beclomethasone dipropionate by Aspergillus niger

0Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

In the present research, the steroidal anti-asthmatic drug beclomethasone dipropionate was subjected to microbial biotransformation by Aspergillus niger. Beclomethasone dipropionate was transformed into various metabolites first time from microbial transformation. New drug metabolites produced can act as new potential drug molecules and can replace the old drugs in terms of safety, efficacy, and least resistance. They were purified by preparative thin layer chromatography technique, and their structures were elucidated using modern spectroscopic techniques, such as13C NMR,1H NMR, HMQC, HMQC, COSY, and NOESY, and mass spectrometry, such as EI-MS. Four metabolites were purified: (i) beclomethasone 17-monopropionate, (ii) beclomethasone 21-monopropionate, (iii) beclomethasone, and (iv) 9beta,11beta-epoxy-17,21-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-propionate.

Cite

CITATION STYLE

APA

Ahmad, S., Khaliq, F. H., Madni, A., Shahid, M. N., & Pervaiz, I. (2014). Microbial biotransformation of beclomethasone dipropionate by Aspergillus niger. Brazilian Journal of Pharmaceutical Sciences, 50(4), 903–910. https://doi.org/10.1590/S1984-82502014000400026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free